ATLANTA and MIAMI, Feb. 12, 2020 (GLOBE NEWSWIRE) -- Vivex Biologics, Inc., a leading regenerative medicine company specializing in the development of naturally sourced, biologically engineered tissue products, today announced the appointment of Chad Kolean as chief financial officer. “We are delighted to welcome Chad during this exciting time of growth at Vivex,” said Peter Wehrly, chief executive officer of Vivex. “Chad has an extensive track record of successfully leading operational, M&a
February 12, 2020
· 2 min read